JF
NTLA icon

Jump Financial’s Intellia Therapeutics NTLA Stock Holding History

Jump Financial’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
81,430
+8,090
+11% +$113K 0.01% 1043
2026
Q1 		$940K Buy
+73,340
New +$934K 0.01% 955
2025
Q4 		– Sell
-277,092
Closed -$4.79M – 2186
2025
Q3 		$4.79M Sell
277,092
-179,509
-39% -$2.21M 0.06% 422
2025
Q2 		$4.28M Sell
456,601
-47,208
-9% -$388K 0.05% 467
2025
Q1 		$3.58M Buy
503,809
+141,172
+39% +$1.43M 0.05% 417
2024
Q4 		$4.23M Buy
362,637
+175,885
+94% +$2.74M 0.09% 301
2024
Q3 		$3.84M Buy
+186,752
New +$4.31M 0.08% 297
2024
Q2 		– Sell
-52,560
Closed -$1.45M – 2115
2024
Q1 		$1.45M Buy
+52,560
New +$1.46M 0.04% 599
2023
Q4 		– Sell
-14,295
Closed -$452K – 2087
2023
Q3 		$452K Buy
+14,295
New +$555K 0.02% 1079
2023
Q1 		– Sell
-67,192
Closed -$2.34M – 1909
2022
Q4 		$2.34M Buy
67,192
+58,840
+705% +$2.8M 0.12% 226
2022
Q3 		$467K Sell
8,352
-64,048
-88% -$3.97M 0.02% 921
2022
Q2 		$3.75M Buy
72,400
+27,846
+62% +$1.41M 0.16% 173
2022
Q1 		$3.24M Buy
44,554
+33,831
+315% +$2.87M 0.14% 180
2021
Q4 		$1.27M Sell
10,723
-1,077
-9% -$135K 0.08% 314
2021
Q3 		$1.58M Buy
+11,800
New +$1.79M 0.11% 199
2021
Q1 		– Sell
-5,400
Closed -$294K – 1178
2020
Q4 		$294K Buy
+5,400
New +$196K 0.05% 606

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Jump Financial's NTLA Position: Q2 2026 in Review

Jump Financial increased its Intellia Therapeutics (NTLA) stake by 11% in Q2 2026, buying an estimated $113K and bringing the position to 81,430 shares worth $1.38M. The position accounts for 0.01% of the portfolio, ranked #1043.

Jump Financial first reported a position in NTLA in Q4 2020 and has held it in 16 quarters since. The position peaked at $4.79M in Q3 2025. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Jump Financial held 81,430 shares of Intellia Therapeutics worth $1.38M as of Q2 2026.
  • Jump Financial bought 8,090 Intellia Therapeutics shares in Q2 2026, an estimated $113K.
  • Intellia Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1043 holding.
  • Jump Financial first reported a position in Intellia Therapeutics in Q4 2020 and has held it in 16 quarters since.
  • Jump Financial's Intellia Therapeutics position peaked at $4.79M in Q3 2025.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.